Ariel Ekblaw

to figure out, they basically did a parameter sweep looking at the crystallization of the drug in space.

And the amazing thing for Keytruda is they figured out a way to get more precise, consistent size of the crystallization of the drug, and it took it from an IV drug to a shot.

So huge for patient quality of life.

You don't have to go into a hospital to get Keytruda.

Well, what they did, that's the magic of some of the tools now that we have on Earth.

To your earlier point that some of the things on Earth are getting so close to being good for space, for the Keytruda, the cancer drug, they use space to do this parameter sweep of a bunch of data that would have been really hard to get on Earth.

And then they figured out what it was.

Exactly.

Exactly right.

But then they were able to figure out how to mimic part of the parameters that they did get in space on the ground so they don't have to make every dose of Keytruda on the International Space Station.

So there's two examples, tissue engineering, it's physical, it's at a macro scale, even though we think of it as tiny, it's really macro scale for biology.

That's good for those of us who want to build real estate and have a reason to expand our footprint in orbit.

And then there's protein formulation and crystallization where maybe we get the data from space and then we help use that to inform Earth-based processes.

Made in space.

Made in space.

There is a great company called Made in Space.

They got acquired a couple years ago.

They're doing 3D printing, like what you were asking about.

And yeah, this is what we want to do with our first version of Tesserae, which is what we call the self-assembling ball.

Mm-hmm.